 |
| |
| |
| |
| |
| |
| |
|
| TissGeneSummary for CHEK1 |
 Gene summary |
| Basic gene information | Gene symbol | CHEK1 |
| Gene name | checkpoint kinase 1 | |
| Synonyms | CHK1 | |
| Cytomap | UCSC genome browser: 11q24.2 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001114121.2, NM_001114122.2,NM_001244846.1,NM_001274.5,NR_045204.1, NR_045205.1, | |
| Description | CHK1 checkpoint homologCheckpoint, S. pombe, homolog of, 1Chk1-Scell cycle checkpoint kinasecheckpoint kinase-1serine/threonine-protein kinase Chk1 | |
| Modification date | 20141222 | |
| dbXrefs | MIM : 603078 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000149554 | ||
| HPRD : 04356 | ||
| Vega : OTTHUMG00000165853 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_CHEK1 | |
| BioGPS: 1111 | ||
| Pathway | NCI Pathway Interaction Database: CHEK1 | |
| KEGG: CHEK1 | ||
| REACTOME: CHEK1 | ||
| Pathway Commons: CHEK1 | ||
| Context | iHOP: CHEK1 | |
| ligand binding site mutation search in PubMed: CHEK1 | ||
| UCL Cancer Institute: CHEK1 | ||
| Assigned class in TissGDB* | C | |
| Included tissue-specific gene expression resources | TiGER,GTEx | |
| Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | CervixTestis | |
| Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | CESCTGCT | |
| Reference showing the relevant tissue of CHEK1 | ||
| Description by TissGene annotations | Cancer gene TissgsLTS Fused withOncogene | |
| * Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO term | PubMed ID | GO:0000077 | DNA damage checkpoint | 16963448 | GO:0006975 | DNA damage induced protein phosphorylation | 16963448 | GO:0010569 | regulation of double-strand break repair via homologous recombination | 15665856 | GO:0018107 | peptidyl-threonine phosphorylation | 15665856 | GO:0045839 | negative regulation of mitosis | 15311285 | GO:0046602 | regulation of mitotic centrosome separation | 15311285 | GO:0000077 | DNA damage checkpoint | 16963448 | GO:0006975 | DNA damage induced protein phosphorylation | 16963448 | GO:0010569 | regulation of double-strand break repair via homologous recombination | 15665856 | GO:0018107 | peptidyl-threonine phosphorylation | 15665856 | GO:0045839 | negative regulation of mitosis | 15311285 | GO:0046602 | regulation of mitotic centrosome separation | 15311285 |
| Top |
| TissGeneExp for CHEK1 |
| Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
 |
| Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
 |
| Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| - Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
| Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
| LIHC | -1.512060393 | -2.759754393 | 1.247694 | 5.89E-12 | 9.99E-11 |
| BRCA | -0.67300106 | -1.843313341 | 1.170312281 | 7.36E-23 | 6.43E-22 |
| LUAD | -0.693196462 | -2.703889566 | 2.010693103 | 2.88E-20 | 6.15E-19 |
| LUSC | 0.287294038 | -2.631405962 | 2.9187 | 1.06E-37 | 3.98E-35 |
| COAD | 0.39359253 | -0.726834393 | 1.120426923 | 4.99E-15 | 3.04E-13 |
| STAD | -0.124321893 | -1.350906268 | 1.226584375 | 1.52E-11 | 2.63E-09 |
| BLCA | 0.02090508 | -1.747668604 | 1.768573684 | 2.45E-07 | 1.09E-05 |
| HNSC | 0.019955142 | -1.153935556 | 1.173890698 | 3.48E-12 | 1.06E-10 |
| ESCA | -0.186202575 | -2.157593484 | 1.971390909 | 5.66E-06 | 0.000899131 |
| Top |
| TissGene-miRNA for CHEK1 |
| Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
| Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
| Top |
| TissGeneMut for CHEK1 |
| TissGeneSNV for CHEK1 |
| nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
 |
 |
| Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
 |
| - nsSNVs sorted by frequency. |
| AAchange | Cancer type | # samples |
| p.D130Y | LUSC | 1 |
| p.K337X | LIHC | 1 |
| p.R419S | LUSC | 1 |
| p.R442W | STAD | 1 |
| p.G324C | LUAD | 1 |
| p.E223A | COAD | 1 |
| p.K166N | UCEC | 1 |
| p.M1T | LUSC | 1 |
| p.E32D | KIRP | 1 |
| p.X477C | PRAD | 1 |
| p.R160L | ESCA | 1 |
| p.R160H | UCEC | 1 |
| p.D235N | UCEC | 1 |
| p.T279I | LIHC | 1 |
| p.K232N | GBM | 1 |
| p.G289* | LUSC | 1 |
| p.F93V | STAD | 1 |
| p.E309K | BLCA | 1 |
| p.R29G | LGG | 1 |
| p.I58V | LGG | 1 |
| p.S284L | STAD | 1 |
| p.R379* | HNSC | 1 |
| p.K337* | LIHC | 1 |
| p.R160C | LGG | 1 |
| p.R160C | SKCM | 1 |
| p.D235Y | LUSC | 1 |
| p.G72V | THYM | 1 |
| p.V46A | LUAD | 1 |
| p.V312M | THCA | 1 |
| p.R109* | LUAD | 1 |
| p.G446D | LUAD | 1 |
| p.H122Y | LUAD | 1 |
| p.G324C | SARC | 1 |
| p.Q295E | BLCA | 1 |
| p.S296F | SKCM | 1 |
| p.D336N | STAD | 1 |
| p.L136F | CESC | 1 |
| p.R322H | COAD | 1 |
| p.R156W | READ | 1 |
| p.V119F | ESCA | 1 |
| p.R322H | LIHC | 1 |
| p.R379Q | STAD | 1 |
| p.M167L | GBM | 1 |
| p.R141S | LUAD | 1 |
| p.R160H | GBM | 1 |
| Top |
| TissGeneCNV for CHEK1 |
| Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
 |
| Top |
| TissGeneFusions for CHEK1 |
| Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
| Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
| Chimerdb3.0 | ChiTaRs | NA | CB142976 | CHEK1-DCAF8 | chr11:125499303 | chr1:160248873 | |
| Chimerdb3.0 | FusionScan | ESCA | TCGA-L5-A4OW-01A | CTNNB1-CHEK1 | 5'UTR-5'UTR | chr3:41241161 | chr11:125496643 |
| TCGAfusionPortal | PRADA | BRCA | TCGA-OL-A66P-01A | TMEM135-CHEK1 | CDS-3UTR | Chr11:86802437 | Chr11:125545823 |
| TCGAfusionPortal | PRADA | OV | TCGA-09-1665-01B | CHEK1-EXOC6 | Out-of-frame | Chr11:125505428 | Chr10:94757231 |
| Top |
| TissGeneNet for CHEK1 |
| Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
| BRCA (tumor) | BRCA (normal) |
| CHEK1, SQSTM1, TP53, XRCC5, UBC, HSP90AB1, YWHAG, MEN1, RAD51, TCF4, MSH6, CLSPN, PCNA, SFN, DNMT1, BLM, CDC25A, MSH2, CDC25C, TIMELESS, LATS2 (tumor) | CHEK1, HSP90AB1, YWHAG, RAD51, POLA1, XPO1, MSH6, CLSPN, PCNA, RB1, DNMT1, BLM, PRKDC, CDC25A, FANCE, XRCC6, MSH2, CDC25C, CDC25B, TIMELESS, NEK9 (normal) |
 |  |
| COAD (tumor) | COAD (normal) |
| CHEK1, SQSTM1, BRCA1, XRCC5, RAD51, POLA1, XPO1, MSH6, HSP90AA1, ATR, CLSPN, PCNA, DNMT1, BLM, CDC25A, FANCE, XRCC6, MSH2, CDC25C, CDC25B, TIMELESS (tumor) | CHEK1, BRCA1, HSP90AB1, MEN1, RAD51, POLA1, XPO1, MSH6, CLSPN, PCNA, DDB1, DNMT1, BLM, PRKDC, CDC25A, FANCE, XRCC6, MSH2, CDC25C, TIMELESS, LATS2 (normal) |
 |  |
| HNSC (tumor) | HNSC (normal) |
| CHEK1, SQSTM1, TP53, BRCA1, XRCC5, MEN1, RAD51, SMAD4, TCF4, CLSPN, PCNA, SFN, CUL4A, DDB1, DNMT1, SIRT5, CDC25A, FANCE, CDC25C, TIMELESS, NEK9 (tumor) | CHEK1, BRCA1, CDKN1A, RAD51, POLA1, XPO1, MSH6, CHUK, CLSPN, PCNA, SFN, MCPH1, DNMT1, BLM, ATM, PRKDC, CDC25A, MSH2, CDC25C, CDC25B, TIMELESS (normal) |
 |  |
| KICH (tumor) | KICH (normal) |
| CHEK1, BRCA1, XRCC5, RELA, CUL1, AATF, ATR, SIRT1, PCNA, RB1, XIAP, CUL4A, BLM, ATM, MDM4, CDC25A, FANCE, MSH2, TIMELESS, LATS2, PIGM (tumor) | CHEK1, BRCA1, UBC, CDKN1A, USP7, MEN1, RAD51, CHUK, CLSPN, CSNK2B, PCNA, RB1, XIAP, UBA52, CUL4A, MCPH1, DNMT1, CDC25A, FANCE, TLK1, CDC25C (normal) |
 |  |
| KIRC (tumor) | KIRC (normal) |
| CHEK1, BRCA1, XRCC5, UBC, RAD51, XPO1, CLSPN, PCNA, SFN, RB1, BLM, PSME1, MDM4, FANCE, XRCC6, MSH2, CDC25C, CDC25B, TIMELESS, LATS2, PIGM (tumor) | CHEK1, CSNK2A1, BRCA1, HSP90AB1, YWHAG, RAD51, POLA1, AATF, TCF4, XPO1, MSH6, BIRC2, CLSPN, PCNA, BLM, CDC25A, XRCC6, MSH2, CDC25C, CDC25B, TIMELESS (normal) |
 |  |
| KIRP (tumor) | KIRP (normal) |
| CHEK1, SQSTM1, CDKN1A, HSP90AB1, RAD51, POLA1, COPS5, HSP90AA1, SIRT1, CSNK2B, PCNA, RB1, CUL4A, PSME1, FANCE, XRCC6, CDC25B, TIMELESS, LATS2, NEK9, PIGM (tumor) | CHEK1, BRCA1, MEN1, RAD51, POLA1, COPS5, AATF, MSH6, AKT1, CLSPN, PCNA, UBA52, DDB1, DNMT1, BLM, CDC25A, FANCE, MSH2, CDC25C, TIMELESS, LATS2 (normal) |
 |  |
| LIHC (tumor) | LIHC (normal) |
| CHEK1, CDKN1A, RELA, HSP90AB1, USP7, YWHAG, MEN1, RAD51, CUL1, COPS5, MSH6, CHUK, ATR, CSNK2B, PCNA, RB1, UBA52, DNMT1, PSME1, SIRT5, LATS2 (tumor) | CHEK1, CSNK2A1, BRCA1, XRCC5, RAD51, POLA1, AATF, MSH6, CLSPN, CSNK2B, PCNA, DNMT1, BLM, PRKDC, CDC25A, FANCE, XRCC6, MSH2, CDC25C, CDC25B, TIMELESS (normal) |
 |  |
| LUAD (tumor) | LUAD (normal) |
| CHEK1, TP53, XRCC5, USP7, RAD51, CUL1, COPS5, SIRT1, CLSPN, CSNK2B, PCNA, XIAP, UBA52, BLM, PSME1, CDC25A, FANCE, XRCC6, MSH2, CDC25C, LATS2 (tumor) | CHEK1, BRCA1, XRCC5, YWHAG, RAD51, POLA1, AATF, XPO1, MSH6, BIRC2, HSP90AA1, CLSPN, PCNA, DDB1, DNMT1, BLM, PRKDC, CDC25A, MSH2, CDC25C, TIMELESS (normal) |
 |  |
| LUSC (tumor) | LUSC (normal) |
| CHEK1, TP53, BRCA1, UBC, RELA, YWHAG, MEN1, RAD51, XPO1, BIRC2, ATR, SIRT1, CLSPN, PCNA, DNMT1, BLM, CDC25A, MSH2, TLK1, CDC25C, TIMELESS (tumor) | CHEK1, CSNK2A1, BRCA1, CDKN1A, MEN1, RAD51, POLA1, XPO1, MSH6, HSP90AA1, CLSPN, PCNA, DNMT1, BLM, PRKDC, CDC25A, MSH2, CDC25C, CDC25B, TIMELESS, LATS2 (normal) |
 |  |
| PRAD (tumor) | PRAD (normal) |
| CHEK1, SQSTM1, CSNK2A1, TP53, BRCA1, USP7, YWHAG, MEN1, RAD51, AATF, SMAD4, AKT1, SIRT1, CLSPN, PCNA, SFN, XIAP, DDB1, BLM, CDC25A, LATS2 (tumor) | CHEK1, MEN1, RAD51, COPS5, AATF, TCF4, CHUK, ATR, SIRT1, CSNK2B, PCNA, RB1, XIAP, UBA52, CUL4A, ATM, SIRT5, PRKDC, CDC25A, CDC25C, LATS2 (normal) |
 |  |
| STAD (tumor) | STAD (normal) |
| CHEK1, CSNK2A1, TP53, YWHAG, MEN1, RAD51, CUL1, TCF4, BIRC2, AKT1, SIRT1, CLSPN, PCNA, SFN, BLM, CDC25A, TLK1, CDC25C, TIMELESS, LATS2, NEK9 (tumor) | CHEK1, CSNK2A1, BRCA1, XRCC5, MEN1, RAD51, POLA1, TCF4, XPO1, MSH6, CLSPN, PCNA, DNMT1, BLM, PRKDC, CDC25A, FANCE, MSH2, CDC25C, CDC25B, TIMELESS (normal) |
 |  |
| THCA (tumor) | THCA (normal) |
| CHEK1, CSNK2A1, RAD51, AATF, SMAD4, ATR, SIRT1, CSNK2B, PCNA, XIAP, UBA52, CUL4A, BLM, PSME1, XRCC6, MSH2, CDC25C, CDC25B, TIMELESS, LATS2, NEK9 (tumor) | CHEK1, CSNK2A1, USP7, RAD51, SMAD4, TCF4, CHUK, ATR, SIRT1, CSNK2B, PCNA, RB1, XIAP, UBA52, CUL4A, MCPH1, PSME1, PRKDC, CDC25C, LATS2, NEK9 (normal) |
 |  |
| Top |
| TissGeneProg for CHEK1 |
| Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
 |
| Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Top |
| TissGeneClin for CHEK1 |
| TissGeneDrug for CHEK1 |
| Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
| DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Top |
| TissGeneDisease for CHEK1 |
| Disease information associated with TissGene (DisGeNet, 2016-06-01) |
| Disease ID | Disease name | # pubmeds | Source |
| umls:C0006142 | Malignant neoplasm of breast | 28 | BeFree,GAD |
| umls:C0678222 | Breast Carcinoma | 23 | BeFree |
| umls:C0029925 | Ovarian Carcinoma | 13 | BeFree |
| umls:C1140680 | Malignant neoplasm of ovary | 11 | BeFree |
| umls:C0015625 | Fanconi Anemia | 9 | BeFree,LHGDN |
| umls:C0004135 | Ataxia Telangiectasia | 8 | BeFree |
| umls:C0235974 | Pancreatic carcinoma | 8 | BeFree |
| umls:C0023418 | leukemia | 7 | BeFree |
| umls:C0025202 | melanoma | 7 | BeFree |
| umls:C0242379 | Malignant neoplasm of lung | 7 | BeFree,GAD |
| umls:C0346647 | Malignant neoplasm of pancreas | 7 | BeFree |
| umls:C1527249 | Colorectal Cancer | 7 | BeFree,GAD |
| umls:C2239176 | Liver carcinoma | 7 | BeFree,LHGDN |
| umls:C0009402 | Colorectal Carcinoma | 6 | BeFree |
| umls:C0023467 | Leukemia, Myelocytic, Acute | 6 | BeFree |
| umls:C0596263 | Carcinogenesis | 6 | BeFree |
| umls:C0302592 | Cervix carcinoma | 5 | BeFree |
| umls:C0684249 | Carcinoma of lung | 5 | BeFree |
| umls:C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 5 | BeFree |
| umls:C3539878 | Triple Negative Breast Neoplasms | 5 | BeFree |
| umls:C0007102 | Malignant tumor of colon | 4 | BeFree |
| umls:C0007131 | Non-Small Cell Lung Carcinoma | 4 | BeFree |
| umls:C0017638 | Glioma | 4 | BeFree,GAD |
| umls:C0699790 | Colon Carcinoma | 4 | BeFree |
| umls:C0007137 | Squamous cell carcinoma | 3 | BeFree |
| umls:C0007847 | Malignant tumor of cervix | 3 | BeFree |
| umls:C0024299 | Lymphoma | 3 | BeFree |
| umls:C0024623 | Malignant neoplasm of stomach | 3 | BeFree |
| umls:C0280100 | Solid tumour | 3 | BeFree |
| umls:C0376358 | Malignant neoplasm of prostate | 3 | BeFree |
| umls:C0600139 | Prostate carcinoma | 3 | BeFree |
| umls:C1458155 | Mammary Neoplasms | 3 | BeFree,CTD_human |
| umls:C0005684 | Malignant neoplasm of urinary bladder | 2 | BeFree,GAD |
| umls:C0012860 | DNA Damage | 2 | GAD |
| umls:C0026764 | Multiple Myeloma | 2 | BeFree |
| umls:C0027819 | Neuroblastoma | 2 | BeFree |
| umls:C0029463 | Osteosarcoma | 2 | BeFree,LHGDN |
| umls:C0035335 | Retinoblastoma | 2 | BeFree |
| umls:C0085390 | Li-Fraumeni Syndrome | 2 | BeFree |
| umls:C0178874 | Tumor Progression | 2 | BeFree |
| umls:C0346153 | Breast Cancer, Familial | 2 | BeFree |
| umls:C0677886 | Epithelial ovarian cancer | 2 | BeFree,GAD |
| umls:C0699791 | Stomach Carcinoma | 2 | BeFree |
| umls:C0700095 | Central neuroblastoma | 2 | BeFree |
| umls:C2931822 | Nasopharyngeal carcinoma | 2 | BeFree |
| umls:C0001418 | Adenocarcinoma | 1 | BeFree |
| umls:C0001486 | Adenovirus Infections | 1 | BeFree |
| umls:C0002871 | Anemia | 1 | BeFree |
| umls:C0002894 | Refractory anaemia with excess blasts | 1 | BeFree |
| umls:C0004134 | Ataxia | 1 | BeFree |
| umls:C0006118 | Brain Neoplasms | 1 | GAD |
| umls:C0006840 | Candidiasis | 1 | BeFree |
| umls:C0007103 | Malignant neoplasm of endometrium | 1 | BeFree |
| umls:C0007124 | Noninfiltrating Intraductal Carcinoma | 1 | BeFree |
| umls:C0009207 | Cockayne Syndrome | 1 | BeFree |
| umls:C0009375 | Colonic Neoplasms | 1 | GAD,LHGDN |
| umls:C0009404 | Colorectal Neoplasms | 1 | LHGDN |
| umls:C0017661 | IGA Glomerulonephritis | 1 | CTD_human |
| umls:C0023470 | Myeloid Leukemia | 1 | BeFree |
| umls:C0024117 | Chronic Obstructive Airway Disease | 1 | GAD |
| umls:C0024121 | Lung Neoplasms | 1 | BeFree |
| umls:C0024301 | Lymphoma, Follicular | 1 | BeFree |
| umls:C0024305 | Lymphoma, Non-Hodgkin | 1 | LHGDN |
| umls:C0025007 | Measles | 1 | BeFree |
| umls:C0025286 | Meningioma | 1 | GAD |
| umls:C0025958 | Microcephaly | 1 | BeFree,LHGDN |
| umls:C0027019 | Myelomonocytic leukemia | 1 | BeFree |
| umls:C0027627 | Neoplasm Metastasis | 1 | BeFree |
| umls:C0027859 | Acoustic Neuroma | 1 | GAD |
| umls:C0030297 | Pancreatic Neoplasm | 1 | GAD |
| umls:C0031117 | Peripheral Neuropathy | 1 | CTD_human |
| umls:C0032578 | Polyploidy | 1 | CTD_human |
| umls:C0032580 | Adenomatous Polyposis Coli | 1 | BeFree |
| umls:C0032927 | Precancerous Conditions | 1 | BeFree |
| umls:C0033578 | Prostatic Neoplasms | 1 | LHGDN |
| umls:C0038356 | Stomach Neoplasms | 1 | BeFree |
| umls:C0043346 | Xeroderma Pigmentosum | 1 | BeFree |
| umls:C0085669 | Acute leukemia | 1 | BeFree |
| umls:C0149925 | Small cell carcinoma of lung | 1 | BeFree |
| umls:C0152013 | Adenocarcinoma of lung (disorder) | 1 | BeFree |
| umls:C0153252 | Systemic candidiasis | 1 | BeFree |
| umls:C0206708 | Cervical Intraepithelial Neoplasia | 1 | BeFree |
| umls:C0238033 | Carcinoma of Male Breast | 1 | BeFree |
| umls:C0242787 | Malignant neoplasm of male breast | 1 | BeFree |
| umls:C0265202 | Seckel syndrome | 1 | BeFree |
| umls:C0333516 | Tumor necrosis | 1 | BeFree |
| umls:C0334108 | Multiple polyps | 1 | BeFree |
| umls:C0476089 | Endometrial Carcinoma | 1 | BeFree |
| umls:C0585442 | Osteosarcoma of bone | 1 | BeFree |
| umls:C0686619 | Secondary malignant neoplasm of lymph node | 1 | BeFree |
| umls:C0699885 | Carcinoma of bladder | 1 | BeFree |
| umls:C0887833 | Carcinoma, Pancreatic Ductal | 1 | GAD |
| umls:C0920269 | Microsatellite Instability | 1 | GAD |
| umls:C1096616 | Contralateral breast cancer | 1 | BeFree |
| umls:C1512981 | Mammary Tumorigenesis | 1 | BeFree |
| umls:C1559154 | Rash and Dermatitis Adverse Event Associated with Chemoradiation | 1 | BeFree |
| umls:C1883486 | Uterine Corpus Cancer | 1 | BeFree |
| umls:C1955934 | Trichothiodystrophy Syndromes | 1 | BeFree |
| umls:C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | BeFree |
| umls:C3711387 | Autosomal Recessive Primary Microcephaly | 1 | BeFree |
Copyright 2016-Present - The University of Texas Health Science Center at Houston (UTHealth) Web File Viewing | How to Report, Fraud, Waste and Abuse | State of Texas | Statewide Search | Texas Homeland Security | Site Policies |